BUY Cipla Ltd. — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)26 Jul 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
5 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·24 Jul · today
Earning Estimates: Infosys, Cipla, IndiGo, Meesho, Mphasis & Allied Blenders Q1 Results Today — What To Expect
NewsNdtv-Profit·23 Jul · yesterday
Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street
NewsLivemint·20 Jul · 4d ago
3 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·7 Jul · 2w ago
Q1 Results Highlights: Motilal Oswal operating profit rises 14% to ₹609 crore
NewsCnbc-Tv18·23 Jul · today
Q1 Results Today Highlights: Infosys, Airtel Africa, PVR INOX post strong numbers; IndiGo, Cipla and Meesho deliver mixed results
NewsHbl·23 Jul · today
Cipla Ltd announces a change in its Chief Financial Officer (CFO) role. Mr. Ashish Adukia transitions to an internal business leadership role, relinquishing his CFO position. Mr. Dinesh Jain is appoin
BSE · Company Update·23 Jul · yesterday
Cipla Ltd announced changes in its finance leadership. Mr. Ashish Adukia transitions from Global CFO to an internal business leadership role, relinquishing his KMP position. Mr. Dinesh Jain is appoint
BSE · Board Meeting·23 Jul · yesterday
Cipla announced changes in its finance leadership. Ashish Adukia transitions from Global CFO to an internal role, and Dinesh Jain is appointed as the new Global CFO and KMP, effective July 24, 2026.
NSE · Outcome of Board Meeting·23 Jul · yesterday
Cipla shares rise 3.7% despite Q1 profit fall, brokerages remain cautious
NewsHbl·24 Jul · today
2 advisors have active short-term SELL calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·24 Jul · today
2 other SEBI-registered advisors have active long-term SELL calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·24 Jul · today
Cipla Q1 results: Profit falls 39% YoY to ₹789.05 crore
NewsLivemint·23 Jul · yesterday
Cipla Q1 results: Profit falls 39% YoY to ₹789 crore; revenue climbs 3.50%
NewsLivemint·23 Jul · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cipla
- BUY — Ashish Bahety, Profitmart Securities29 Sept 2026 · Same day · target ₹1,420 · Expired
- BUY — Ashish Bahety, Profitmart Securities29 Sept 2026 · Same day · target ₹1,430 · Expired
- BUY — Rajesh Palviya, Axis Securities29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY — Arun Kumar Mantri28 Sept 2026 · ~1 year · target ₹1,900 · Active
- BUY — Arun Kumar Mantri25 Sept 2026 · Same day · target ₹1,428 · SL hit
More from ICICI Securities
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹969 · Active
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active

